Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model

Authors: Mesfin Yimam, Jifu Zhao, Brandon Corneliusen, Mandee Pantier, Lidia Brownell, Qi Jia

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

There are a few nutritional approaches to address the increased needs of managing diabetic conditions. Previously it has been reported that UP780, a standardized composition of aloe chromone formulated with an aloe polysaccharide, has a significant impact in reducing HbA1C, fasting blood glucose, fructosamine and plasma insulin level in humans and improved impaired glucose and insulin resistance in high-fat diet-induced and db/db non-insulin dependent diabetic mouse models. Here we describe activity of UP780 and its constituents to improve insulin sensitivity in alloxan induced insulin dependent diabetic mouse model.

Materials and method

Insulin dependent diabetes was induced by administering a single intraperitoneal injection of alloxan monohydrate at a dose of 150 mg/kg to CD-1 mice. Aloesin (UP394) was formulated with an Aloe vera inner leaf gel powder polysaccharide (Qmatrix) to yield a composition designated UP780. Efficacy of oral administration of UP780 at 2000 mg/kg and its constituents (aloesin at 80 mg/kg and Qmatrix at 1920 mg/kg) were evaluated in this model. Glyburide, a sulfonylurea drug used in the treatment of type 2 diabetes, was used at 5 mg/kg as a positive control. Effect of UP780 on non-diabetic normal mice was also addressed.

Results

Mice administered intraperitoneal alloxan monohydrate developed progressive type-1 diabetes like symptom. After 4 weeks of daily oral administration, reductions of 35.9%, 17.2% and 11.6% in fasting blood glucose levels were observed for UP780, the UP780 Aloe vera inner leaf gel polysaccharide preparation without chromone (Qmatrix), and Aloesin (UP394), treated animals respectively, compared to vehicle treated animals. UP780 has no impact on blood glucose level of non-diabetic healthy mice. UP780 showed statistically significant improvement for blood glucose clearance in oral glucose tolerance tests. Similarly, enhanced improvement in plasma insulin level and statistically significant reduction in triglyceride level was also observed for animals treated with the composition.

Conclusion

These findings suggest that UP780, a chromone standardized Aloe based composition, could possibly be used as a natural supplement alternative to facilitate maintenance of healthy blood glucose levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cohen IK, Diegelmann RF, Lindblad WJ: Wound Healing: Biochemical & Clinical Aspects. 1992, Philadelphia: Saunders Cohen IK, Diegelmann RF, Lindblad WJ: Wound Healing: Biochemical & Clinical Aspects. 1992, Philadelphia: Saunders
2.
go back to reference Grindlay D, Reynolds T: The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol. 1986, 16: 117-151. 10.1016/0378-8741(86)90085-1.CrossRefPubMed Grindlay D, Reynolds T: The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol. 1986, 16: 117-151. 10.1016/0378-8741(86)90085-1.CrossRefPubMed
3.
go back to reference Hart LA, van Enckevort PH, van Dijk H, Zaat R, de Silva KT, Labadie RP: Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. J Ethnopharmacol. 1988, 23: 61-71. 10.1016/0378-8741(88)90115-8.CrossRefPubMed Hart LA, van Enckevort PH, van Dijk H, Zaat R, de Silva KT, Labadie RP: Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. J Ethnopharmacol. 1988, 23: 61-71. 10.1016/0378-8741(88)90115-8.CrossRefPubMed
4.
go back to reference Yagi A, Kanbara T, Morinobu N: Inhibition of mushroom-tyrosinase by aloe extract. Planta Med. 1987, 53: 515-517. 10.1055/s-2006-962798.CrossRefPubMed Yagi A, Kanbara T, Morinobu N: Inhibition of mushroom-tyrosinase by aloe extract. Planta Med. 1987, 53: 515-517. 10.1055/s-2006-962798.CrossRefPubMed
5.
go back to reference Yu BP, Lee KY: Identification of potent antioxidant from Aloe barbadensis. U.S. Patent No. 5, 939, 395 Yu BP, Lee KY: Identification of potent antioxidant from Aloe barbadensis. U.S. Patent No. 5, 939, 395
6.
go back to reference Ajabnoor MA: Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol. 1990, 28: 215-220. 10.1016/0378-8741(90)90031-N.CrossRefPubMed Ajabnoor MA: Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol. 1990, 28: 215-220. 10.1016/0378-8741(90)90031-N.CrossRefPubMed
7.
go back to reference Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N: The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res. 1986, 24: 288-294. 10.1159/000180569.CrossRefPubMed Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N: The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res. 1986, 24: 288-294. 10.1159/000180569.CrossRefPubMed
8.
go back to reference Jones K, Hughes J, Hong M, Jia Q, Orndorff S: Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 2002, 15: 335-340. 10.1034/j.1600-0749.2002.02014.x.CrossRefPubMed Jones K, Hughes J, Hong M, Jia Q, Orndorff S: Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 2002, 15: 335-340. 10.1034/j.1600-0749.2002.02014.x.CrossRefPubMed
9.
go back to reference Lee KY, Park JH, Chung MH, Park YI, Kim KW, Lee YJ, Lee SK: Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. Biochem Mol Biol Int. 1997, 41: 285-292.PubMed Lee KY, Park JH, Chung MH, Park YI, Kim KW, Lee YJ, Lee SK: Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. Biochem Mol Biol Int. 1997, 41: 285-292.PubMed
10.
go back to reference Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST: Antiinflammatory C-glucosyl chromone from Aloe barbadensis. J Nat Prod. 1996, 59: 541-543. 10.1021/np9601519.CrossRefPubMed Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST: Antiinflammatory C-glucosyl chromone from Aloe barbadensis. J Nat Prod. 1996, 59: 541-543. 10.1021/np9601519.CrossRefPubMed
11.
go back to reference Lee KY, Weintraub ST, Yu BP: Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Free Radic Biol Med. 2000, 28: 261-265. 10.1016/S0891-5849(99)00235-X.CrossRefPubMed Lee KY, Weintraub ST, Yu BP: Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Free Radic Biol Med. 2000, 28: 261-265. 10.1016/S0891-5849(99)00235-X.CrossRefPubMed
12.
go back to reference Adeyi AO, Idowu BA, Mafiana CF, Oluwalana SA, Ajayi OL, Akinloye OA: Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathology. Int J Physiol Pathophysiol Pharmacol. 2012, 4: 51-58.PubMedCentralPubMed Adeyi AO, Idowu BA, Mafiana CF, Oluwalana SA, Ajayi OL, Akinloye OA: Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathology. Int J Physiol Pathophysiol Pharmacol. 2012, 4: 51-58.PubMedCentralPubMed
13.
go back to reference Xu Z, Wang X, Zhou M, Ma L, Deng Y, Zhang H, Zhao A, Zhang Y, Jia W: The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats. Phytother Res. 2008, 22: 97-101. 10.1002/ptr.2273.CrossRefPubMed Xu Z, Wang X, Zhou M, Ma L, Deng Y, Zhang H, Zhao A, Zhang Y, Jia W: The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats. Phytother Res. 2008, 22: 97-101. 10.1002/ptr.2273.CrossRefPubMed
14.
go back to reference Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002, 51: 1851-1858. 10.2337/diabetes.51.6.1851.CrossRefPubMed Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002, 51: 1851-1858. 10.2337/diabetes.51.6.1851.CrossRefPubMed
15.
go back to reference Harach T, Aprikian O, Monnard I, Moulin J, Membrez M, Beolor JC, Raab T, Mace K, Darimont C: Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med. 2010, 76: 566-571. 10.1055/s-0029-1240612.CrossRefPubMed Harach T, Aprikian O, Monnard I, Moulin J, Membrez M, Beolor JC, Raab T, Mace K, Darimont C: Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med. 2010, 76: 566-571. 10.1055/s-0029-1240612.CrossRefPubMed
16.
go back to reference Rajasekaran S, Sivagnanam K, Subramanian S: Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep. 2005, 57: 90-96.PubMed Rajasekaran S, Sivagnanam K, Subramanian S: Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep. 2005, 57: 90-96.PubMed
17.
go back to reference Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S: Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol. 2006, 33: 232-237. 10.1111/j.1440-1681.2006.04351.x.CrossRefPubMed Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S: Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol. 2006, 33: 232-237. 10.1111/j.1440-1681.2006.04351.x.CrossRefPubMed
18.
go back to reference al-Awadi F, Fatania H, Shamte U: The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res. 1991, 18: 163-168.PubMed al-Awadi F, Fatania H, Shamte U: The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res. 1991, 18: 163-168.PubMed
19.
go back to reference Rajasekaran S, Sivagnanam K, Subramanian S: Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J Pharm Pharmacol. 2005, 57: 241-246. 10.1211/0022357055416.CrossRefPubMed Rajasekaran S, Sivagnanam K, Subramanian S: Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J Pharm Pharmacol. 2005, 57: 241-246. 10.1211/0022357055416.CrossRefPubMed
20.
go back to reference Parihar MS, Chaudhary M, Shetty R, Hemnani T: Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci. 2004, 11: 397-402. 10.1016/j.jocn.2003.09.008.CrossRefPubMed Parihar MS, Chaudhary M, Shetty R, Hemnani T: Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci. 2004, 11: 397-402. 10.1016/j.jocn.2003.09.008.CrossRefPubMed
21.
go back to reference Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Alper O, Yanardag R: Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian J Exp Biol. 2004, 42: 48-52.PubMed Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Alper O, Yanardag R: Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian J Exp Biol. 2004, 42: 48-52.PubMed
22.
go back to reference Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A: Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull. 2004, 27: 694-698. 10.1248/bpb.27.694.CrossRefPubMed Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A: Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull. 2004, 27: 694-698. 10.1248/bpb.27.694.CrossRefPubMed
23.
go back to reference Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, Lee YH, Lee YR, Oh ST, Jo TH, Park YI, Lee CK, Kim K: Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine. 2009, 16: 856-863. 10.1016/j.phymed.2009.02.014.CrossRefPubMed Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, Lee YH, Lee YR, Oh ST, Jo TH, Park YI, Lee CK, Kim K: Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine. 2009, 16: 856-863. 10.1016/j.phymed.2009.02.014.CrossRefPubMed
24.
go back to reference Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell LA, Jia Q: UP780, a chromone-enriched aloe composition improves insulin sensitivity. Metab Syndr Relat Disord. 2013, 11: 267-275. 10.1089/met.2012.0135.CrossRefPubMed Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell LA, Jia Q: UP780, a chromone-enriched aloe composition improves insulin sensitivity. Metab Syndr Relat Disord. 2013, 11: 267-275. 10.1089/met.2012.0135.CrossRefPubMed
25.
go back to reference Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, Toida T, Hayasawa H, Takase M, Inagaki M, Higuchi R: Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull. 2006, 29: 1418-1422. 10.1248/bpb.29.1418.CrossRefPubMed Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, Toida T, Hayasawa H, Takase M, Inagaki M, Higuchi R: Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull. 2006, 29: 1418-1422. 10.1248/bpb.29.1418.CrossRefPubMed
26.
go back to reference Agarwal OP: Prevention of atheromatous heart disease. Angiology. 1985, 36: 485-492. 10.1177/000331978503600801.CrossRefPubMed Agarwal OP: Prevention of atheromatous heart disease. Angiology. 1985, 36: 485-492. 10.1177/000331978503600801.CrossRefPubMed
27.
go back to reference Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine. 1996, 3: 241-243. 10.1016/S0944-7113(96)80060-2.CrossRefPubMed Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine. 1996, 3: 241-243. 10.1016/S0944-7113(96)80060-2.CrossRefPubMed
28.
go back to reference Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine. 1996, 3: 245-248. 10.1016/S0944-7113(96)80061-4.CrossRefPubMed Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine. 1996, 3: 245-248. 10.1016/S0944-7113(96)80061-4.CrossRefPubMed
29.
go back to reference Nasiff HA, Fajardo FR, Velez F: Effect of aloe on hyperlipidemia in patients with negative response to diet. Revista Cubana Med Gen Integral. 1993, 9: 43-51. Nasiff HA, Fajardo FR, Velez F: Effect of aloe on hyperlipidemia in patients with negative response to diet. Revista Cubana Med Gen Integral. 1993, 9: 43-51.
30.
go back to reference Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q: Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013, 11: 35-40. 10.1089/met.2012.0066.CrossRefPubMed Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q: Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013, 11: 35-40. 10.1089/met.2012.0066.CrossRefPubMed
31.
go back to reference Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH: Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012, 78: 311-316. 10.1055/s-0031-1280474.CrossRefPubMed Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH: Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012, 78: 311-316. 10.1055/s-0031-1280474.CrossRefPubMed
32.
go back to reference Chung CH, Hao E, Piran R, Keinan E, Levine F: Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells. 2010, 28: 1630-1638. 10.1002/stem.482.CrossRefPubMed Chung CH, Hao E, Piran R, Keinan E, Levine F: Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells. 2010, 28: 1630-1638. 10.1002/stem.482.CrossRefPubMed
33.
go back to reference Okyar A, Can A, Akev N, Baktir G, Sutlupinar N: Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res. 2001, 15: 157-161. 10.1002/ptr.719.CrossRefPubMed Okyar A, Can A, Akev N, Baktir G, Sutlupinar N: Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res. 2001, 15: 157-161. 10.1002/ptr.719.CrossRefPubMed
34.
go back to reference Patanè G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F: Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol. 2000, 129: 887-892. 10.1038/sj.bjp.0703131.PubMedCentralCrossRefPubMed Patanè G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F: Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol. 2000, 129: 887-892. 10.1038/sj.bjp.0703131.PubMedCentralCrossRefPubMed
35.
go back to reference Beppu H, Koike T, Shimpo K, Chihara T, Hoshino M, Ida C, Kuzuya H: Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet B-cell destruction in rats. J Ethnopharmacol. 2003, 89: 37-45. 10.1016/S0378-8741(03)00268-X.CrossRefPubMed Beppu H, Koike T, Shimpo K, Chihara T, Hoshino M, Ida C, Kuzuya H: Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet B-cell destruction in rats. J Ethnopharmacol. 2003, 89: 37-45. 10.1016/S0378-8741(03)00268-X.CrossRefPubMed
36.
go back to reference Jain N, Vijayaraghavan R, Pant SC, Lomash V, Ali M: Aloe vera gel alleviates cardiotoxicity in streptozocin-induced diabetes in rats. J Pharm Pharmacol. 2010, 62: 115-123. 10.1211/jpp.62.01.0013.CrossRefPubMed Jain N, Vijayaraghavan R, Pant SC, Lomash V, Ali M: Aloe vera gel alleviates cardiotoxicity in streptozocin-induced diabetes in rats. J Pharm Pharmacol. 2010, 62: 115-123. 10.1211/jpp.62.01.0013.CrossRefPubMed
37.
go back to reference Lenzen S: The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008, 51: 216-226. 10.1007/s00125-007-0886-7.CrossRefPubMed Lenzen S: The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008, 51: 216-226. 10.1007/s00125-007-0886-7.CrossRefPubMed
Metadata
Title
Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model
Authors
Mesfin Yimam
Jifu Zhao
Brandon Corneliusen
Mandee Pantier
Lidia Brownell
Qi Jia
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-61

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue